| Title : Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology - O'Brien_2016_J.Psychopharmacol_31_147 |
| Author(s) : O'Brien JT , Holmes C , Jones M , Jones R , Livingston G , McKeith I , Mittler P , Passmore P , Ritchie C , Robinson L , Sampson EL , Taylor JP , Thomas A , Burns A |
| Ref : J Psychopharmacol , 31 :147 , 2016 |
| Abstract : O'Brien_2016_J.Psychopharmacol_31_147 |
| ESTHER : O'Brien_2016_J.Psychopharmacol_31_147 |
| PubMedSearch : O'Brien_2016_J.Psychopharmacol_31_147 |
| PubMedID: 28103749 |
O'Brien JT, Holmes C, Jones M, Jones R, Livingston G, McKeith I, Mittler P, Passmore P, Ritchie C, Robinson L, Sampson EL, Taylor JP, Thomas A, Burns A (2016)
Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology
J Psychopharmacol
31 :147
O'Brien JT, Holmes C, Jones M, Jones R, Livingston G, McKeith I, Mittler P, Passmore P, Ritchie C, Robinson L, Sampson EL, Taylor JP, Thomas A, Burns A (2016)
J Psychopharmacol
31 :147